Subscription Information for Nurse Practitioners
Published quarterly, MPR Nurse Practitioners' Edition provides product monographs and prescribing information on over 4,300 products and includes NP Association listings. [Subscribe/Renew]
Change the address for your subscription
To update your information, please click here
When you will receive your subscription
MPR Nurse Practitioners' Edition is a quarterly publication; therefore, the first issue will not arrive until the next quarter, depending upon your date of application. For the approximate date of your first issue, see schedule below:
| If your subscription is received by...
|| March 31
|| June 30
|| Sept 30
|| Dec 31
| Your first edition will be...
| Approx. mail date (allow 2 weeks for delivery)
|| May 10
|| Aug 16
|| Nov 14
|| Feb 25
|If you cannot wait for the next publish date, a single copy of the current edition can be purchased.|
Claim a missed or damaged issue
We do not generally replace missed issues unless it is damaged by the mailing process or missing pages. We will send you a postpaid envelope to return the damaged copy back to us with your replacement. To claim an issue due to damage or misprint, please call 646-638-6062 (M-F, 9am-5pm EST).
My subscription stopped, what should I do...
Only paid subscriptions are guaranteed continuous service. Complimentary subscriptions for individuals who meet established qualifications will be served as quantities allow. To guarantee receipt of every issue of the publication, click here.
Sign Up for Free e-newsletters
- 2016 Recommended Immunization Schedule for Adults: What's Changed?
- First Sexually-Transmitted Zika Virus Case Confirmed in Texas
- 2016 Childhood and Adolescent Immunization Schedule Released
- Spiriva Respimat Gains Indication and New Dosage Strength
- To Rx or Not to Rx: Interventions to Improve Antibiotic Prescribing for Uncomplicated Acute RTI
- CDC Guidelines on Preventing Sexual Transmission of Zika Virus Issued
- CDC Updates Interim Zika Virus Guidelines for Pregnant Women and Women of Reproductive Age
- Daklinza Use Expanded to Cover Treatment in More HCV Patients
- Researchers Call for an Alternative Tdap Immunization Strategy for Adolescents
- FDA Announces Large Action Plan in Effort to Reverse the Opioid Epidemic